Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

Related Citations for PubMed (Select 8555746)

1.

The use of opiate antagonists for recurrent self-injurious behavior.

Buzan RD, Thomas M, Dubovsky SL, Treadway J.

J Neuropsychiatry Clin Neurosci. 1995 Fall;7(4):437-44. Review.

PMID:
8555746
2.

Opiate antagonists for recurrent self-injurious behavior in three mentally retarded adults.

Buzan RD, Dubovsky SL, Treadway JT, Thomas M.

Psychiatr Serv. 1995 May;46(5):511-2.

PMID:
7627682
3.

Naltrexone treatment of dementia with severe self-injurious behaviors: a single case study.

Vance HB, Kauffmann C, Pumariega AJ, Del Mundo A.

Psychiatry. 2000 Fall;63(3):288-99.

PMID:
11125673
4.

Naltrexone treatment for a 3-year-old boy with self-injurious behavior.

White T, Schultz SK.

Am J Psychiatry. 2000 Oct;157(10):1574-82. No abstract available.

PMID:
11007709
5.

Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.

Elchaar GM, Maisch NM, Augusto LM, Wehring HJ.

Ann Pharmacother. 2006 Jun;40(6):1086-95. Epub 2006 May 30. Review.

PMID:
16735648
6.

Naltrexone as a treatment of self-injurious behavior: a case report.

Griengl H, Dantendorfer K.

Eur Psychiatry. 2001 Apr;16(3):193-4. No abstract available.

PMID:
11353600
7.

Naltrexone treatment of self-injurious behavior.

Godart NT, Agman G, Perdereau F, Jeammet P.

J Am Acad Child Adolesc Psychiatry. 2000 Sep;39(9):1076-8. No abstract available.

PMID:
10986803
8.

Naltrexone as a treatment of self-injurious behavior--a case report.

Griengl H, Sendera A, Dantendorfer K.

Acta Psychiatr Scand. 2001 Mar;103(3):234-6.

PMID:
11240582
9.

Naltrexone and self-injurious behavior: a retrospective population study.

Casner JA, Weinheimer B, Gualtieri CT.

J Clin Psychopharmacol. 1996 Oct;16(5):389-94.

PMID:
8889912
10.

Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.

Roth AS, Ostroff RB, Hoffman RE.

J Clin Psychiatry. 1996 Jun;57(6):233-7.

PMID:
8666558
11.

Using analog baselines to assess the effects of naltrexone on self-injurious behavior.

Garcia D, Smith RG.

Res Dev Disabil. 1999 Jan-Feb;20(1):1-21.

PMID:
9987807
13.

Long-term effects of naltrexone on self-injurious behavior.

Sandman CA, Hetrick W, Taylor DV, Marion SD, Touchette P, Barron JL, Martinezzi V, Steinberg RM, Crinella FM.

Am J Ment Retard. 2000 Mar;105(2):103-17.

PMID:
10755174
14.

[Detoxication in opiate addiction and prevention of recurrence: administration of naltrexone and cognitive behavior therapy].

Roozen HG, Deden AL, Kerkhof AJ, Vorsteveld JP, van den Brink W.

Ned Tijdschr Geneeskd. 1997 Dec 6;141(49):2377-80. Dutch.

PMID:
9554156
15.

Clinical uses of naltrexone: a review of the evidence.

Modesto-Lowe V, Van Kirk J.

Exp Clin Psychopharmacol. 2002 Aug;10(3):213-27. Review.

PMID:
12233982
16.

Preliminary study of altered skin temperature at body sites associated with self-injurious behavior in adults who have developmental disabilities.

Symons FJ, Sutton KA, Bodfish JW.

Am J Ment Retard. 2001 Jul;106(4):336-43. Erratum in: Am J Ment Retard 2001 Sep;106(5):469.

PMID:
11414874
17.

Behavioral naltrexone therapy: an integrated treatment for opiate dependence.

Rothenberg JL, Sullivan MA, Church SH, Seracini A, Collins E, Kleber HD, Nunes EV.

J Subst Abuse Treat. 2002 Dec;23(4):351-60.

PMID:
12495797
18.

Concurrent substance use and outcome in combined behavioral and naltrexone therapy for opiate dependence.

Church SH, Rothenberg JL, Sullivan MA, Bornstein G, Nunes EV.

Am J Drug Alcohol Abuse. 2001 Aug;27(3):441-52.

PMID:
11506261
19.

[Limited role of naltrexone in the treatment of opiate addiction].

van Brussel GH.

Ned Tijdschr Geneeskd. 2001 Jul 28;145(30):1452-6. Review. Dutch.

PMID:
11503313
20.

[Treatment of dissociative symptoms in borderline personality disorder with naltrexone: supplementary comments].

Schmahl C, Bohus M.

Nervenarzt. 2000 May;71(5):427. German. No abstract available.

PMID:
10846724
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk